Research Article
Investigation of Anti-Toxocara and Anti-Toxoplasma Antibodies in Patients with Schizophrenia Disorder
Table 7
The distribution of latent toxoplasmosis according to the age in patients with schizophrenia disorder and healthy controls.
| | Patients’ group | Healthy | Sig | OR | CI95 | | (%) | (%) |
| Age (years) | | | | | | <20 | 0 (0%) | 0/4 (0%) | | | | 20–29 | 10/32 (32.25%) | 37/83 (44.57%) | 0.1 | 2.9 | 0.68–12.51 | 30–39 | 14/34 (41.17%) | 5/7 (71.42%) | 0.1 | 0.2 | 0.04–1.5 | 40–49 | 6/23 (26.08%) | 0/0 (0%) | | | | >50 | 4/11 (36.36%) | 1/1 (100%) | 0.4 | 0.3 | 0.1–0.7 |
|
|